Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akili, Inc.

Akili, Inc. (AKLI) Stock Overview

Explore Akili, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AKLI●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.43
$0.001(0.25%)
U.S. Market opens in 63h 24m

Akili, Inc. (AKLI)

Meyka AI Score

Z

Key Financials

Market Cap34.1M
P/E Ratio-0.57
EPS (TTM)$-0.61
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

AKLI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akili, Inc. (NASDAQ: AKLI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Akili, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AKLI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Akili, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.57 and a market capitalization of 34.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AKLI on the NASDAQ.

Price Performance (NASDAQ: AKLI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.37%
3-Month Change
8.28%
6-Month Change
72.48%
Year-to-Date (YTD) Change
-9.34%
1-Year Change
-63.61%
3-Year Change
-95.60%
5-Year Change
-95.72%
All-Time (Max) Change
-95.72%

Contact Information

https://www.akiliinteractive.com
617-456-0597
125 Broad Street, Boston, MA, 02110

Company Facts

680 Employees
IPO DateJun 30, 2021
CountryUS

Frequently Asked Questions